Science ❯ Medical Research ❯ Vaccine Development ❯ Infectious Diseases

mRNA Vaccines

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

Citing failure of mRNA vaccines against upper respiratory infections, he redirected resources toward broader vaccine platforms beyond mRNA.

HHS Withdraws $766 Million From Moderna’s Bird Flu Vaccine Program